Our policy in the Medical Programs Department of the National Psoriasis Foundation (NPF) is to ensure balance, independence, objectivity, and scientific rigor in all our educational programs.  Anyone presenting or participating in the planning of any NPF CME programs is expected to disclose to the Medical Programs Department any real or apparent affiliation(s) within the past 12 months that may have a direct bearing on the subject matter of the continuing medical education program.  The intent of this policy is to ensure continuing medical education programs that are free of commercial interests.

The Allied Healthcare Recognition Provider Program faculty and planning committee have disclosed the following relationships with commercial interests:

Paul Yamauchi, M.D., Ph.D: Advisor – Eli Lilly
Consultant – Abbvie, Amgen, Baxter, Janssen-Ortho, Novartis, Pfizer
Speaker – Abbvie, Amgen, Galderma, Janssen-Ortho, Leo, Novartis
Principle Investigator – Amgen, Celgene, Galderma, Janssen-Ortho, Leo,  Eli Lilly, Pfizer

April Armstrong, M.D.
Consultant – Abbvie, Amgen, Janssen, Merck, Eli Lilly, Novartis, Pfizer, Celgene
Investigator - Abbvie, Janssen, Eli Lilly

Jennifer Soung, M.D.
Advisor - Eli Lilly; Investigator - Allergan, Amgen, Celgene, Eli Lilly, Genentech, Genzum, Janssen, Kadmon, Merz, Pfizer, Regeneron
Speaker – Abbvie, Amgen, Celgene
Stockholder - Pfizer

Planning Committee:  Susan Hardin has disclosed no relevant financial interests with any commercial interests.